Phototherapy such as photothermal therapy and photodynamic therapy in cancer treatment
has been developed quickly over the past few years for its noninvasive nature and high …

The development of cancer nanotherapeutics has attracted great interest in the recent
decade. Cancer nanotherapeutics have overcome several limitations of conventional …

Cancer immunotherapy, or the utilization of the body's immune system to attack tumor cells,
has gained prominence over the past few decades as a viable cancer treatment strategy …

A thermal “window” of immunogenic cell death (ICD) elicited by nanoparticle‐based
photothermal therapy (PTT) in an animal model of neuroblastoma is described. In studies …

Photothermal therapy (PTT) is of particular importance as a highly potent therapeutic
modality in cancer therapy. However, a critical challenge still remains in the exploration of …

Prussian blue (PB) is a coordination polymer studied since the early 18th century,
historically known as a pigment. PB can be prepared in colloidal form with a straightforward …

Triple‐negative breast cancer (TNBC) accounts for 15–25% of breast cancer cases and
lacks expression of the three most common receptors seen on other subtypes of breast …

High-risk neuroblastoma, which is associated with regional and systemic metastasis, is a
leading cause of cancer-related mortality in children. Responding to this need for novel …

Prussian blue nanoparticle‐based photothermal therapy (PBNP‐PTT) is an effective tumor
treatment capable of eliciting an antitumor immune response. Motivated by the ability of …

Despite the promise of immunotherapy such as the immune checkpoint inhibitors (ICIs) anti-
PD-1 and anti-CTLA-4 for advanced melanoma, only 26%–52% of patients respond, and …